Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cumberland Pharmaceutical...

    NASDAQ: CPIX · Real-Time Price · USD
    3.95
    -0.40 (-9.20%)
    At close: Jun 23, 2025, 3:59 PM

    Cumberland Pharmaceuticals Statistics

    Share Statistics

    Cumberland Pharmaceuticals has 14.96M shares outstanding. The number of shares has increased by -1.57% in one year.

    Shares Outstanding

    n/a
    		 14.96M

    Shares Change (YoY)

    n/a
    		 -1.57%

    Shares Change (QoQ)

    n/a
    		 -0.53%

    Owned by Institutions (%)

    n/a
    		 13.11%

    Shares Floating

    n/a
    		 8.34M

    Failed to Deliver (FTD) Shares

    n/a
    		 171

    FTD / Avg. Volume

    n/a
    		 0.44%

    Short Selling Information

    The latest short interest is 62.72K, so 0.42% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 62.72K

    Short % of Shares Out

    n/a
    		 0.42%

    Short % of Float

    n/a
    		 0.72%

    Short Ratio (days to cover)

    n/a
    		 1.42

    Valuation Ratios

    The PE ratio is -5.14 and the forward PE ratio is -8.37. Cumberland Pharmaceuticals's PEG ratio is -1.13.

    PE Ratio

    n/a
    		 -5.14

    Forward PE

    n/a
    		 -8.37

    PS Ratio

    n/a
    		 0.88

    Forward PS

    n/a
    		 1.3

    PB Ratio

    n/a
    		 1.46

    P/FCF Ratio

    n/a
    		 -42.08

    PEG Ratio

    n/a
    		 -1.13
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Cumberland Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.15, with a Debt / Equity ratio of 0.9.

    Current Ratio

    n/a
    		 1.15

    Quick Ratio

    n/a
    		 1.03

    Debt / Equity

    n/a
    		 0.9

    Debt / EBITDA

    n/a
    		 112.77

    Debt / FCF

    n/a
    		 -25.98

    Interest Coverage

    n/a
    		 -11.73

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $416,131.26

    Profits Per Employee

    n/a
    		 $-71,206.26

    Employee Count

    n/a
    		 91

    Asset Turnover

    n/a
    		 0.5

    Inventory Turnover

    n/a
    		 1.65

    Taxes

    Income Tax

    n/a
    		 -22.67K

    Effective Tax Rate

    n/a
    		 0.35%

    Stock Price Statistics

    The stock price has increased by 163.33% in the last 52 weeks. The beta is -0.29, so Cumberland Pharmaceuticals's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.29

    52-Week Price Change

    n/a
    		 163.33%

    50-Day Moving Average

    n/a
    		 5

    200-Day Moving Average

    n/a
    		 3.23

    Relative Strength Index (RSI)

    n/a
    		 35.22

    Average Volume (20 Days)

    n/a
    		 39,053

    Income Statement

    In the last 12 months, Cumberland Pharmaceuticals had revenue of 37.87M and earned -6.48M in profits. Earnings per share was -0.46.

    Revenue

    n/a
    		 37.87M

    Gross Profit

    n/a
    		 26.38M

    Operating Income

    n/a
    		 -7.1M

    Net Income

    n/a
    		 -6.48M

    EBITDA

    n/a
    		 182.42K

    EBIT

    n/a
    		 -5.86M

    Earnings Per Share (EPS)

    n/a
    		 -0.46
    Full Income Statement

    Balance Sheet

    The company has 17.96M in cash and 20.57M in debt, giving a net cash position of -2.61M.

    Cash & Cash Equivalents

    n/a
    		 17.96M

    Total Debt

    n/a
    		 20.57M

    Net Cash

    n/a
    		 -2.61M

    Retained Earnings

    n/a
    		 -23.97M

    Total Assets

    n/a
    		 69.94M

    Working Capital

    n/a
    		 6.36M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -612.19K and capital expenditures -179.71K, giving a free cash flow of -791.9K.

    Operating Cash Flow

    n/a
    		 -612.19K

    Capital Expenditures

    n/a
    		 -179.71K

    Free Cash Flow

    n/a
    		 -791.9K

    FCF Per Share

    n/a
    		 -0.06
    Full Cash Flow Statement

    Margins

    Gross margin is 69.66%, with operating and profit margins of -18.75% and -17.11%.

    Gross Margin

    n/a
    		 69.66%

    Operating Margin

    n/a
    		 -18.75%

    Pretax Margin

    n/a
    		 -17.08%

    Profit Margin

    n/a
    		 -17.11%

    EBITDA Margin

    n/a
    		 0.48%

    EBIT Margin

    n/a
    		 -18.75%

    FCF Margin

    n/a
    		 -2.09%

    Dividends & Yields

    CPIX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for CPIX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 1.37

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist